Many patients with ovarian cancer have misconceptions about the care they will receive while on a clinical trial, according to Laurel W. Rice, M.D.
BY Laurel W. Rice, M.D.
PUBLISHED April 23, 2018
Clinical trials lead to new advancements in ovarian cancer, but many patients may be apprehensive to go on them. So, it is crucial that they understand what a trial is all about, according to Laurel W. Rice, M.D., chair of the Department of Obstetrics and Gynecology and a professor in the Division of Gynecologic Oncology at the University of Wisconsin-Madison School of Medicine and Public Health, and president of the Society for Gynecologic Oncology (SGO).
While some trials do include an arm of patients who receive a placebo, many more actually compare an investigative medicine versus a standard-of-care treatment, so all participants are getting treated. SGO was involved in developing an easy-to-understand video that helps patients better understand clinical trials.